This study explores whether pre-endoscopy use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) leads to delayed gastric emptying and retained stomach contents.
The findings clarify the safety of performing endoscopy in patients on GLP-1 RAs, addressing concerns about increased aspiration risk.
A multicenter cross-sectional analysis of patients undergoing upper endoscopy, comparing retained gastric content volumes between GLP-1 RA users and non-users.
Contrary to prior concerns, GLP-1 RA use was associated with lower retained gastric contents.
Routine withholding of GLP-1 RAs before upper endoscopy may not be necessary, though clinical judgment should guide decision-making.